Detalhe da pesquisa
1.
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.
Hepatology
; 79(5): 1220-1238, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37934656
2.
Recent Advances in the Management of Primary Sclerosing Cholangitis.
Clin Gastroenterol Hepatol
; 21(8): 2065-2075, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37084929
3.
Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis.
Hepatology
; 76(6): 1862-1879, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35611859
4.
Research gaps and opportunities in autoimmune hepatitis-Results of the international autoimmune hepatitis group research workshop 2022.
Liver Int
; 43(7): 1375-1384, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37035872
5.
Advancing Second-Line Treatment for Primary Biliary Cholangitis.
N Engl J Med
; 390(9): 853-854, 2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38381658
6.
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study.
Hepatology
; 73(6): 2099-2109, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33713486
7.
Role of Biliary Organoids in Cholestasis Research and Regenerative Medicine.
Semin Liver Dis
; 41(2): 206-212, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33957696
8.
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 18(1): 179-187.e6, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31100458
9.
Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile.
Hepatology
; 70(3): 871-882, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30561836
10.
The Contribution of B Cells in Autoimmune Liver Diseases.
Semin Liver Dis
; 39(4): 422-431, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31226726
11.
Clinical utility of genomic analysis in adults with idiopathic liver disease.
J Hepatol
; 70(6): 1214-1221, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31000363
12.
Reply: Living donor liver transplantation for people with PSC.
Hepatology
; 77(5): E97-E98, 2023 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36732294
13.
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.
Hepatology
; 77(2): 659-702, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36083140
14.
Reply: Insurance should cover vancomycin for primary sclerosing cholangitis.
Hepatology
; 77(6): E176-E177, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36695291
15.
Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process.
Gastroenterology
; 161(6): 1764-1775.e5, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34384749
16.
Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled Trials.
Hepatology
; 73(3): 887-889, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33403699
17.
Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study.
J Clin Gastroenterol
; 51(2): e11-e16, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27428727
18.
Machine Learning in a Complex Disease: PREsTo Improves the Prognostication of Primary Sclerosing Cholangitis.
Hepatology
; 71(1): 8-10, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31850533
19.
Fibrates and cholestasis.
Hepatology
; 62(2): 635-43, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25678132
20.
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.
Hepatology
; 72(2): 671-722, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31863477